Article

Low zinc levels at clinical admission associates with poor outcomes in COVID-19

2020-10-11

Abstract excerpt

<h4>Background</h4> Biomarkers to predict Coronavirus disease-19 (COVID-19) outcome early at infection are urgently needed to improve prognosis and treatment. Zinc balances immune responses and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with more severe COVID-19 outcomes. We hyp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f5b2ab73-5152-5202-a234-771bd07e004c
DOI: 10.1101/2020.10.07.20208645

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low zinc levels at clinical admission associates with poor outcomes in COVID-19DOI 10.1101/2020.10.07.20208645Read

Low Zinc Levels at Clinical Admission Associates with Poor Outcomes in COVID-19Semantic proximity Read

The Predictive Power of Serum Vitamin D for Poor Outcomes in COVID-19 PatientsSemantic proximity Read

Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementationSemantic proximity Read

Dissecting Clinical Features of COVID-19 in a Cohort of 21,312 Acute Care PatientsSemantic proximity Read

Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on ReproductionSemantic proximity Read

The Relation Between Trace Element Status (Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection During PregnancySemantic proximity Read

Host and Viral Zinc-Finger Proteins in COVID-19Semantic proximity Read

Micronutrients Deficiency, Supplementation and Novel Coronavirus Infections–A Systematic Review and Meta-AnalysisSemantic proximity Read

COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series StudySemantic proximity Read

Resveratrol and Zinc in the Treatment of Outpatients With COVID-19 – The Reszinate Study - A Phase 1/2 Randomized Clinical Trial Utilizing Home Patient-Obtained Nasal and Saliva Viral SamplingSemantic proximity Read

Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19Semantic proximity Read

COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25(OH)D3: Results of a systematic review and meta-analysisSemantic proximity Read